313 related articles for article (PubMed ID: 18536908)
1. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans.
Kitamura S; Maeda K; Sugiyama Y
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):617-28. PubMed ID: 18536908
[TBL] [Abstract][Full Text] [Related]
2. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
Kusuhara H; Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.
Li R; Barton HA; Varma MV
Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496
[TBL] [Abstract][Full Text] [Related]
4. The genetic polymorphism of drug transporters: functional analysis approaches.
Ishikawa T; Tsuji A; Inui K; Sai Y; Anzai N; Wada M; Endou H; Sumino Y
Pharmacogenomics; 2004 Jan; 5(1):67-99. PubMed ID: 14683421
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms.
Yoshida K; Maeda K; Sugiyama Y
Annu Rev Pharmacol Toxicol; 2013; 53():581-612. PubMed ID: 23140240
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
9. Drug transporters in drug efficacy and toxicity.
DeGorter MK; Xia CQ; Yang JJ; Kim RB
Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
[TBL] [Abstract][Full Text] [Related]
10. The impact of drug transporters on adverse drug reaction.
Zhou Y; Zhang GQ; Wei YH; Zhang JP; Zhang GR; Ren JX; Duan HG; Rao Z; Wu XA
Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):77-85. PubMed ID: 23338766
[TBL] [Abstract][Full Text] [Related]
11. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
Lu C; Liao M; Cohen L; Xia CQ
Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
[TBL] [Abstract][Full Text] [Related]
12. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
[TBL] [Abstract][Full Text] [Related]
13. Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation.
Liu Z; Liu K
Curr Drug Metab; 2016; 17(5):456-68. PubMed ID: 26750112
[TBL] [Abstract][Full Text] [Related]
14. The role of hepatic transporters in drug elimination.
Funk C
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
[TBL] [Abstract][Full Text] [Related]
15. Effects of drug transporters on volume of distribution.
Grover A; Benet LZ
AAPS J; 2009 Jun; 11(2):250-61. PubMed ID: 19399628
[TBL] [Abstract][Full Text] [Related]
16. Implications of the dominant role of transporters in drug uptake by cells.
Dobson PD; Lanthaler K; Oliver SG; Kell DB
Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
[TBL] [Abstract][Full Text] [Related]
17. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
18. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
Zhou Q; Yu LS; Zeng S
Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
[TBL] [Abstract][Full Text] [Related]
19. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
El-Kattan AF; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
[TBL] [Abstract][Full Text] [Related]
20. In Vivo-to-In Vitro Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach.
Kumar AR; Prasad B; Bhatt DK; Mathialagan S; Varma MVS; Unadkat JD
Drug Metab Dispos; 2020 Jun; 49(6):470-478. PubMed ID: 33824168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
